Rowinsky Eric K
Insider CIK 1318886 · STML Chief Medical Officer · BIND Director · CNDO Director · VSTM Director · NAVB Director · BIIB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BIIB BIOGEN INC. | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 25,844 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2026-05-21 | 2026-05-26 | 36,000 | — | $0 | 52,666 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 24,339 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2025-05-22 | 2025-05-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2025-05-22 | 2025-05-27 | 8,333 | — | $0 | 16,666 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 21,969 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2024-06-18 | 2024-06-20 | 8,333 | — | $0 | 8,333 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-03-11 | 2024-03-13 | 12,572 | — | $0 | 12,572 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,157 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 4,166 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2024-02-15 | 2024-02-20 | 455 | $222.54 | $101.3K | 20,629 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2024-01-01 | 2024-01-03 | 6,666 | — | $0 | 68,797 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2023-06-26 | 2023-06-28 | 960 | — | $0 | 20,174 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2023-05-15 | 2023-05-16 | 62,500 | — | $0 | 62,500 | SEC↗ |
| FBIO Fortress Biotech, Inc. | P Buy | 2023-02-10 | 2023-02-14 | 11,976 | $0.84 | $10.1K | 931,976 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2023-01-01 | 2023-01-04 | 100,000 | — | $0 | 920,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 62,500 | — | $0 | 62,500 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2022-06-15 | 2022-06-17 | 1,370 | — | $0 | 19,214 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-05-12 | 2022-12-20 | 62,500 | — | $0 | 62,500 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2022-01-01 | 2022-04-29 | 100,000 | — | $0 | 820,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2021-07-01 | 2021-07-02 | 775 | — | $0 | 17,844 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | S Sale | 2021-03-02 | 2021-04-09 | 10,000 | $4.45 | $44.5K | 720,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | S Sale | 2021-02-19 | 2021-04-09 | 8,000 | $4.31 | $34.5K | 730,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | S Sale | 2021-02-18 | 2021-04-09 | 6,000 | $4.20 | $25.2K | 738,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | S Sale | 2021-02-16 | 2021-04-09 | 2,000 | $3.86 | $7.7K | 744,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | S Sale | 2021-02-05 | 2021-04-09 | 4,000 | $3.80 | $15.2K | 746,000 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2021-01-01 | 2021-04-09 | 100,000 | — | $0 | 750,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2020-06-03 | 2020-06-05 | 890 | — | $0 | 17,069 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2020-01-01 | 2020-03-13 | 100,000 | — | $0 | 650,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2019-06-21 | 2019-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2019-06-19 | 2019-06-20 | 1,155 | — | $0 | 16,179 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2019-01-01 | 2019-04-12 | 100,000 | — | $0 | 550,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2018-06-12 | 2018-06-14 | 880 | — | $0 | 15,024 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2018-02-20 | 2018-02-22 | 50,000 | — | $0 | 173,764 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2018-02-20 | 2018-02-22 | 50,000 | — | $0 | 341,446 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2018-01-01 | 2018-11-30 | 100,000 | — | $0 | 450,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2017-09-05 | 2024-01-24 | 2,000 | $3.84 | $7.7K | 2,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2017-06-30 | 2017-06-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2017-06-30 | 2017-06-30 | 50,000 | — | $0 | 291,446 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2017-06-13 | 2017-06-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2017-06-07 | 2017-06-09 | 1,055 | — | $0 | 14,144 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2017-01-01 | 2017-01-24 | 100,000 | — | $0 | 350,000 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise deriv | 2016-08-29 | 2016-08-30 | 15,000 | — | $0 | 0 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise | 2016-08-29 | 2016-08-30 | 15,000 | $0.44 | $6.6K | 15,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2016-06-21 | 2016-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-06-08 | 2016-06-09 | 1,060 | — | $0 | 13,065 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2016-04-20 | 2016-04-29 | 28,000 | — | $0 | 224,446 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2016-04-08 | 2016-04-29 | 10,726 | $1.14 | $12.2K | 196,446 | SEC↗ |
| FBIO Fortress Biotech, Inc. | A Award | 2016-01-01 | 2016-01-05 | 100,000 | — | $0 | 250,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2015-06-10 | 2015-06-11 | 695 | — | $0 | 12,005 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2015-04-27 | 2015-04-28 | 10,824 | $15.77 | $170.7K | 143,688 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2015-03-26 | 2015-03-30 | 22,000 | — | $0 | 185,720 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2015-03-20 | 2015-03-23 | 11,667 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-03-20 | 2015-03-23 | 11,667 | $475.00 | $5.54M | 11,310 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2015-03-20 | 2015-03-23 | 11,667 | $59.82 | $697.9K | 22,977 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-03-19 | 2015-03-20 | 2,333 | — | $0 | 11,667 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-03-19 | 2015-03-20 | 2,333 | $59.82 | $139.6K | 13,643 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-19 | 2015-03-20 | 2,333 | $436.14 | $1.02M | 11,310 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-03-17 | 2015-03-18 | 4,667 | — | $0 | 14,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-03-17 | 2015-03-18 | 4,667 | $59.82 | $279.2K | 15,977 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-17 | 2015-03-18 | 4,667 | $425.45 | $1.99M | 11,310 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award | 2015-03-12 | 2015-03-16 | 50,000 | — | $0 | 150,000 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award | 2015-03-12 | 2015-03-16 | 50,000 | — | $0 | 100,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-03-09 | 2015-03-11 | 4,666 | — | $0 | 18,667 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-09 | 2015-03-11 | 4,666 | $417.23 | $1.95M | 11,310 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-03-09 | 2015-03-11 | 4,666 | $59.82 | $279.1K | 15,976 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2015-03-06 | 2015-03-10 | 69,201 | — | $0 | 69,201 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2015-03-06 | 2015-03-10 | 24,379 | — | $0 | 154,512 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2015-02-18 | 2015-02-20 | 1,640 | $13.99 | $22.9K | 130,133 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2014-11-10 | 2014-11-12 | 9,470 | $1.32 | $12.5K | 163,720 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2014-09-03 | 2014-09-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2014-06-12 | 2014-06-16 | 870 | — | $0 | 11,310 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2014-04-25 | 2014-04-28 | 10,879 | $15.01 | $163.3K | 132,073 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2014-04-25 | 2014-04-28 | 300 | $15.70 | $4.7K | 131,773 | SEC↗ |
| [CNDO] CORONADO BIOSCIENCES INC | A Award | 2014-02-20 | 2014-02-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 37,636 | — | $0 | 37,636 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2014-02-14 | 2014-02-19 | 13,986 | — | $0 | 142,952 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2014-02-13 | 2014-02-18 | 20,000 | — | $0 | 154,250 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-01-21 | 2014-01-22 | 2,020 | $310.09 | $626.4K | 10,440 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award deriv | 2013-12-19 | 2013-12-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2013-11-25 | 2013-11-27 | 13,903 | $20.56 | $285.8K | 128,966 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | F Tax w/h | 2013-08-01 | 2013-08-05 | 6,745 | $27.88 | $188.1K | 143,869 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2013-06-12 | 2013-06-13 | 1,305 | — | $0 | 12,460 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2013-04-24 | 2013-08-05 | 149,614 | — | $0 | 149,614 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2013-03-13 | 2013-03-15 | 30,000 | — | $0 | 134,250 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2013-02-21 | 2013-02-26 | 12,250 | — | $0 | 104,250 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2012-09-26 | 2012-09-27 | 30,000 | — | $0 | 92,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2012-06-08 | 2012-06-11 | 2,020 | — | $0 | 11,155 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2012-04-10 | 2012-04-11 | 17,000 | — | $0 | 62,000 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award deriv | 2012-02-10 | 2012-02-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-01-06 | 2012-01-09 | 11,667 | — | $0 | 23,333 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-01-06 | 2012-01-09 | 1,325 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-01-06 | 2012-01-09 | 11,667 | $59.82 | $697.9K | 20,802 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-01-06 | 2012-01-09 | 1,325 | $116.00 | $153.7K | 9,135 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-01-06 | 2012-01-09 | 11,667 | $116.00 | $1.35M | 9,135 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-01-06 | 2012-01-09 | 1,325 | $59.82 | $79.3K | 10,460 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2011-12-09 | 2012-02-22 | 30,000 | — | $0 | 45,000 | SEC↗ |